Reported Tuberculosis in the United States, 2012
ShareCompartir
(PDF - 202k)
Table 58. Reason Therapy Was Extended Beyond 12 Months: Reporting Areas, 20101
| Reporting Area | Total Cases with Therapy Extended2,3 | Reasons Therapy Was Extended | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Rifampin Resistant | Adverse Event | Non-adherence | Failure | Clinically Indicated | Other | ||||||||
| No. | (%) | No. | (%) | No. | (%) | No. | (%) | No. | (%) | No. | (%) | ||
United States | 766 | 72 | (9.4) | 156 | (20.4) | 104 | (13.6) | 7 | (0.9) | 330 | (43.1) | 211 | (27.5) |
Alabama | 4 | 0 | (0.0) | 0 | (0.0) | 0 | (0.0) | 0 | (0.0) | 4 | (100.0) | 0 | (0.0) |
Alaska | 4 | 3 | (75.0) | 2 | (50.0) | 2 | (50.0) | 1 | (25.0) | 0 | (0.0) | 0 | (0.0) |
Arizona | 7 | 0 | (0.0) | 1 | (14.3) | 0 | (0.0) | 0 | (0.0) | 5 | (71.4) | 2 | (28.6) |
Arkansas | 4 | 0 | (0.0) | 1 | (25.0) | 2 | (50.0) | 0 | (0.0) | 1 | (25.0) | 0 | (0.0) |
California | 228 | 16 | (7.0) | 59 | (25.9) | 20 | (8.8) | 0 | (0.0) | 105 | (46.1) | 73 | (32.0) |
Colorado | 4 | 0 | (0.0) | 1 | (25.0) | 1 | (25.0) | 0 | (0.0) | 1 | (25.0) | 1 | (25.0) |
Connecticut | 10 | 1 | (10.0) | 3 | (30.0) | 1 | (10.0) | 0 | (0.0) | 4 | (40.0) | 6 | (60.0) |
Delaware | 1 | 0 | (0.0) | 0 | (0.0) | 0 | (0.0) | 0 | (0.0) | 0 | (0.0) | 1 | (100.0) |
District of Columbia | 1 | 0 | (0.0) | 1 | (100.0) | 0 | (0.0) | 0 | (0.0) | 0 | (0.0) | 0 | (0.0) |
Florida | 41 | 6 | (14.6) | 9 | (22.0) | 3 | (7.3) | 1 | (2.4) | 22 | (53.7) | 6 | (14.6) |
Georgia | 37 | 4 | (10.8) | 1 | (2.7) | 12 | (32.4) | 0 | (0.0) | 22 | (59.5) | 7 | (18.9) |
Hawaii | 3 | 0 | (0.0) | 1 | (33.3) | 0 | (0.0) | 0 | (0.0) | 0 | (0.0) | 3 | (100.0) |
Idaho | 1 | 0 | (0.0) | 0 | (0.0) | 0 | (0.0) | 0 | (0.0) | 1 | (100.0) | 0 | (0.0) |
Illinois | 23 | 1 | (4.3) | 8 | (34.8) | 2 | (8.7) | 1 | (4.3) | 11 | (47.8) | 1 | (4.3) |
Indiana | 4 | 0 | (0.0) | 1 | (25.0) | 1 | (25.0) | 0 | (0.0) | 1 | (25.0) | 2 | (50.0) |
Iowa | 0 | 0 | ... | 0 | ... | 0 | ... | 0 | ... | 0 | ... | 0 | ... |
Kansas | 0 | 0 | ... | 0 | ... | 0 | ... | 0 | ... | 0 | ... | 0 | ... |
Kentucky | 1 | 0 | (0.0) | 1 | (100.0) | 1 | (100.0) | 0 | (0.0) | 0 | (0.0) | 0 | (0.0) |
Louisiana | 13 | 0 | (0.0) | 3 | (23.1) | 2 | (15.4) | 0 | (0.0) | 2 | (15.4) | 6 | (46.2) |
Maine | 0 | 0 | ... | 0 | ... | 0 | ... | 0 | ... | 0 | ... | 0 | ... |
Maryland | 13 | 0 | (0.0) | 1 | (7.7) | 3 | (23.1) | 0 | (0.0) | 6 | (46.2) | 4 | (30.8) |
Massachusetts | 15 | 1 | (6.7) | 7 | (46.7) | 0 | (0.0) | 1 | (6.7) | 6 | (40.0) | 1 | (6.7) |
Michigan | 11 | 0 | (0.0) | 0 | (0.0) | 4 | (36.4) | 0 | (0.0) | 3 | (27.3) | 4 | (36.4) |
Minnesota | 15 | 0 | (0.0) | 4 | (26.7) | 3 | (20.0) | 0 | (0.0) | 8 | (53.3) | 1 | (6.7) |
Mississippi | 4 | 1 | (25.0) | 2 | (50.0) | 0 | (0.0) | 0 | (0.0) | 1 | (25.0) | 0 | (0.0) |
Missouri | 0 | 0 | ... | 0 | ... | 0 | ... | 0 | ... | 0 | ... | 0 | ... |
Montana | 0 | 0 | ... | 0 | ... | 0 | ... | 0 | ... | 0 | ... | 0 | ... |
Nebraska | 2 | 0 | (0.0) | 1 | (50.0) | 0 | (0.0) | 0 | (0.0) | 1 | (50.0) | 0 | (0.0) |
Nevada | 9 | 2 | (22.2) | 4 | (44.4) | 1 | (11.1) | 0 | (0.0) | 3 | (33.3) | 1 | (11.1) |
New Hampshire | 1 | 0 | (0.0) | 1 | (100.0) | 0 | (0.0) | 0 | (0.0) | 0 | (0.0) | 0 | (0.0) |
New Jersey | 23 | 8 | (34.8) | 6 | (26.1) | 1 | (4.3) | 0 | (0.0) | 6 | (26.1) | 10 | (43.5) |
New Mexico | 3 | 1 | (33.3) | 1 | (33.3) | 1 | (33.3) | 0 | (0.0) | 0 | (0.0) | 0 | (0.0) |
New York State4 | 21 | 6 | (28.6) | 3 | (14.3) | 1 | (4.8) | 0 | (0.0) | 7 | (33.3) | 5 | (23.8) |
New York City | 17 | 3 | (17.6) | 3 | (17.6) | 4 | (23.5) | 0 | (0.0) | 4 | (23.5) | 5 | (29.4) |
North Carolina | 18 | 0 | (0.0) | 5 | (27.8) | 2 | (11.1) | 0 | (0.0) | 10 | (55.6) | 5 | (27.8) |
North Dakota | 2 | 0 | (0.0) | 1 | (50.0) | 1 | (50.0) | 0 | (0.0) | 0 | (0.0) | 0 | (0.0) |
Ohio | 7 | 1 | (14.3) | 1 | (14.3) | 0 | (0.0) | 0 | (0.0) | 6 | (85.7) | 0 | (0.0) |
Oklahoma | 4 | 0 | (0.0) | 2 | (50.0) | 0 | (0.0) | 0 | (0.0) | 0 | (0.0) | 2 | (50.0) |
Oregon | 1 | 1 | (100.0) | 0 | (0.0) | 0 | (0.0) | 0 | (0.0) | 0 | (0.0) | 0 | (0.0) |
Pennsylvania | 32 | 4 | (12.5) | 13 | (40.6) | 2 | (6.3) | 0 | (0.0) | 13 | (40.6) | 11 | (34.4) |
Rhode Island | 9 | 0 | (0.0) | 0 | (0.0) | 4 | (44.4) | 0 | (0.0) | 6 | (66.7) | 1 | (11.1) |
South Carolina | 7 | 0 | (0.0) | 2 | (28.6) | 1 | (14.3) | 0 | (0.0) | 4 | (57.1) | 0 | (0.0) |
South Dakota | 0 | 0 | ... | 0 | ... | 0 | ... | 0 | ... | 0 | ... | 0 | ... |
Tennessee | 12 | 0 | (0.0) | 0 | (0.0) | 1 | (8.3) | 0 | (0.0) | 6 | (50.0) | 6 | (50.0) |
Texas | 110 | 7 | (6.4) | 4 | (3.6) | 25 | (22.7) | 2 | (1.8) | 47 | (42.7) | 27 | (24.5) |
Utah | 2 | 1 | (50.0) | 1 | (50.0) | 0 | (0.0) | 0 | (0.0) | 0 | (0.0) | 0 | (0.0) |
Vermont | 0 | 0 | ... | 0 | ... | 0 | ... | 0 | ... | 0 | ... | 0 | ... |
Virginia | 18 | 1 | (5.6) | 2 | (11.1) | 0 | (0.0) | 0 | (0.0) | 5 | (27.8) | 10 | (55.6) |
Washington | 15 | 2 | (13.3) | 0 | (0.0) | 2 | (13.3) | 0 | (0.0) | 4 | (26.7) | 7 | (46.7) |
West Virginia | 0 | 0 | ... | 0 | ... | 0 | ... | 0 | ... | 0 | ... | 0 | ... |
Wisconsin | 8 | 2 | (25.0) | 0 | (0.0) | 1 | (12.5) | 1 | (12.5) | 5 | (62.5) | 2 | (25.0) |
Wyoming | 1 | 0 | (0.0) | 0 | (0.0) | 0 | (0.0) | 0 | (0.0) | 0 | (0.0) | 1 | (100.0) |
American Samoa5 | 0 | 0 | ... | 0 | ... | 0 | ... | 0 | ... | 0 | ... | 0 | ... |
Fed. States of Micronesia5 | 3 | 1 | (33.3) | 1 | (33.3) | 0 | (0.0) | 0 | (0.0) | 0 | (0.0) | 1 | (33.3) |
Guam5 | 2 | 0 | (0.0) | 0 | (0.0) | 1 | (50.0) | 0 | (0.0) | 1 | (50.0) | 0 | (0.0) |
Marshall Islands5 | 1 | 0 | (0.0) | 0 | (0.0) | 1 | (100.0) | 0 | (0.0) | 0 | (0.0) | 0 | (0.0) |
N. Mariana Islands5 | 0 | 0 | ... | 0 | ... | 0 | ... | 0 | ... | 0 | ... | 0 | ... |
Puerto Rico5 | 0 | 0 | ... | 0 | ... | 0 | ... | 0 | ... | 0 | ... | 0 | ... |
Republic of Palau5 | 0 | 0 | ... | 0 | ... | 0 | ... | 0 | ... | 0 | ... | 0 | ... |
U.S. Virgin Islands5 | 0 | 0 | ... | 0 | ... | 0 | ... | 0 | ... | 0 | ... | 0 | ... |
1 Most recent year for which data are available.
2 Among patients who were alive at diagnosis, started on treatment and had a duration of treatment greater than 365 days.
3 Patient may have more than 1 reason therapy was extended beyond 12 months (total reasons therapy extended may be greater than total patients with therapy extended).
4 Excludes New York City.
5 Not included in U.S. totals.
Note: Ellipses indicate data not available.
- Page last reviewed: September 16, 2013
- Page last updated: September 16, 2013
- Content source: